메뉴 건너뛰기




Volumn 96, Issue 23, 2010, Pages 1865-1867

Further insights into syndrome X

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; AZITHROMYCIN; GATIFLOXACIN; PRAVASTATIN;

EID: 78649957579     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.206870     Document Type: Editorial
Times cited : (46)

References (18)
  • 1
    • 68949172538 scopus 로고    scopus 로고
    • Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms
    • Cannon RO. Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms. J Am Coll Cardiol 2009;54:877-5.
    • (2009) J Am Coll Cardiol , vol.54 , pp. 877-885
    • Cannon, R.O.1
  • 2
    • 12544258000 scopus 로고    scopus 로고
    • Angina with "normal" coronary arteries: A changing philosophy
    • Bugiardini R, Bairey Merz CN. Angina with "normal" coronary arteries: a changing philosophy. JAMA 2005;293:477-84.
    • (2005) JAMA , vol.293 , pp. 477-484
    • Bugiardini, R.1    Bairey Merz, C.N.2
  • 3
    • 78649904814 scopus 로고    scopus 로고
    • High prevalence of intramural coronary infection in patients with drug-resistant cardiac syndrome X: Comparison with chronic stable angina and normal controls
    • Chimenti C, Sale P, Verardo R, et al. High prevalence of intramural coronary infection in patients with drug-resistant cardiac syndrome X: comparison with chronic stable angina and normal controls. Heart 2010;96:1926-31.
    • (2010) Heart , vol.96 , pp. 1926-1931
    • Chimenti, C.1    Sale, P.2    Verardo, R.3
  • 4
    • 33846689981 scopus 로고    scopus 로고
    • Cardiac syndrome X: A critical overview and future perspectives
    • Lanza GA. Cardiac syndrome X: a critical overview and future perspectives. Heart 2007;93:159-66.
    • (2007) Heart , vol.93 , pp. 159-166
    • Lanza, G.A.1
  • 5
    • 33745843711 scopus 로고    scopus 로고
    • Unanswered questions for management of acute coronary syndrome: Risk stratification of patients with minimal disease or normal findings on coronary angiography
    • Bugiardini R, Manfrini O, De Ferrari GM. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med 2006;166:1391-5.
    • (2006) Arch Intern Med , vol.166 , pp. 1391-1395
    • Bugiardini, R.1    Manfrini, O.2    De Ferrari, G.M.3
  • 6
    • 13844307291 scopus 로고    scopus 로고
    • Normal angiogram in acute coronary syndrome - Preangiographic risk stratification, angiographic findings and follow-up
    • Germing A, Lindstaedt M, Ulrich S, et al. Normal angiogram in acute coronary syndrome - preangiographic risk stratification, angiographic findings and follow-up. Int J Cardiol 2005;99:19-23.
    • (2005) Int J Cardiol , vol.99 , pp. 19-23
    • Germing, A.1    Lindstaedt, M.2    Ulrich, S.3
  • 7
    • 33847231568 scopus 로고    scopus 로고
    • Coronary microvascular dysfunction
    • Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356:830-40.
    • (2007) N Engl J Med , vol.356 , pp. 830-840
    • Camici, P.G.1    Crea, F.2
  • 8
    • 2642525262 scopus 로고    scopus 로고
    • Endothelial function predicts future development of coronary artery disease: A study of women with chest pain and normal coronary angiograms
    • Bugiardini R, Manfrini O, Pizzi C, et al. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 2004;109:2518-23.
    • (2004) Circulation , vol.109 , pp. 2518-2523
    • Bugiardini, R.1    Manfrini, O.2    Pizzi, C.3
  • 9
    • 33749593476 scopus 로고    scopus 로고
    • Presentation, patterns of myocardial damage, and clinical course of viral myocarditis
    • Mahrholdt H, Wagner A, Deluigi CC, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006;114:1581-90.
    • (2006) Circulation , vol.114 , pp. 1581-1590
    • Mahrholdt, H.1    Wagner, A.2    Deluigi, C.C.3
  • 10
    • 33644850082 scopus 로고    scopus 로고
    • Myocarditis: Current trends in diagnosis and treatment
    • Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation 2006;113:876-90.
    • (2006) Circulation , vol.113 , pp. 876-890
    • Magnani, J.W.1    Dec, G.W.2
  • 11
    • 74549138306 scopus 로고    scopus 로고
    • Role of acute infection in triggering acute coronary syndromes
    • Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010;10:83-92.
    • (2010) Lancet Infect Dis , vol.10 , pp. 83-92
    • Corrales-Medina, V.F.1    Madjid, M.2    Musher, D.M.3
  • 12
    • 3042513531 scopus 로고    scopus 로고
    • Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X
    • Lanza GA, Sestito A, Cammarata G, et al. Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. Am J Cardiol 2004;94:40-4.
    • (2004) Am J Cardiol , vol.94 , pp. 40-44
    • Lanza, G.A.1    Sestito, A.2    Cammarata, G.3
  • 13
    • 20244366215 scopus 로고    scopus 로고
    • Azithromycin for the secondary prevention of coronary events
    • for the ACES Investigators
    • Grayston JT, Kronmal RA, Jackson LA, et al, for the ACES Investigators. Azithromycin for the secondary prevention of coronary events. N Engl J Med 2005;352:1637-45.
    • (2005) N Engl J Med , vol.352 , pp. 1637-1645
    • Grayston, J.T.1    Kronmal, R.A.2    Jackson, L.A.3
  • 14
    • 17244372856 scopus 로고    scopus 로고
    • Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome
    • for the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators
    • Cannon CP, Braunwald E, McCabe CH, et al, for the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med 2005;352:1646-54.
    • (2005) N Engl J Med , vol.352 , pp. 1646-1654
    • Cannon, C.P.1    Braunwald, E.2    McCabe, C.H.3
  • 16
    • 33847661612 scopus 로고    scopus 로고
    • Angina, "normal" coronary angiography, and vascular dysfunction: Risk assessment strategies
    • Bugiardini R, Badimon L, Collins P, et al. Angina, "normal" coronary angiography, and vascular dysfunction: risk assessment strategies. PLoS Med 2007;4:e12.
    • (2007) PLoS Med , vol.4
    • Bugiardini, R.1    Badimon, L.2    Collins, P.3
  • 17
    • 45449088070 scopus 로고    scopus 로고
    • Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis
    • Yilmaz A, Mahrholdt H, Athanasiadis A, et al. Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart 2008;94:1456-63.
    • (2008) Heart , vol.94 , pp. 1456-1463
    • Yilmaz, A.1    Mahrholdt, H.2    Athanasiadis, A.3
  • 18
    • 0346096808 scopus 로고    scopus 로고
    • Angiotensin-Converting Enzyme Inhibitors and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase in Cardiac Syndrome X: Role of Superoxide Dismutase Activity
    • DOI 10.1161/01.CIR.0000100722.34034.E4
    • Pizzi C, Manfrini O, Fontana F, et al. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: role of superoxide dismutase activity. Circulation 2004;109:53-8. (Pubitemid 38056021)
    • (2004) Circulation , vol.109 , Issue.1 , pp. 53-58
    • Pizzi, C.1    Manfrini, O.2    Fontana, F.3    Bugiardini, R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.